Research & Product Safety

A Survey by Questionnaire. Dr. Nyjon K. Eccles BSc MBBS PhD MRCP, The Chiron Clinic, 121 Harley Street & Jerry Yamoa, NHC Ltd.

200 Questionaires sent out. 120 Returned. 60% Response.
Number of Asthma patients: 70
Mean duration of Asthma: 16.4 years
Age Range: 1 - 68 years
Male patients: 49%; Female patients: 41%; Gender unknown: 10%
14 patients aged 1 - 29yrs; 40 patients aged 30 - 59yrs; 15 patients aged 60 - 89yrs

44% of patients who took part in the survey were Caucasian. 25% were African; 12% were Asian; 10% were Afro-Carribean and 9% were of undisclosed origin.

The reported number of attacks in one year experienced by the group before taking Yamoa was 78. Attacks dropped to 22 per year after Yamoa.

On average patients took some form of asthma medication 3.6 times a day before taking Yamoa Powder. The average number of times medication has been required on a daily basis since Yamoa has been taken is 1.7 times a day.

There were 3 hospital admissions amongst the group who responded to the survey before Yamoa was taken. Afterwards, there were none before the survey was completed.

12% of patients found no benefits from taking Yamoa. 19% experienced a mild improvemnt in their condition. 29% reported a CURE. 40% reported a marked improvement in their condition.

Thus 69%, that is 69 people in every 100, experienced AT LEAST a marked improvement in their asthma as a result of taking Yamoa Powder.

Indications show that greater benefits may be achieved the younger the patient. This may be because the condition has not been with younger patients as long as for those in the older group; they may not have the history of stress and illness that older people have, in which case younger immune systems may be stronger than old. The younger group most likely does not have other contributing factors such as life-long smoking history etc.

A Survey by Questionnaire. Dr. Nyjon K. Eccles BSc MBBS PhD MRCP, The Chiron Clinic, 121 Harley Street & Jerry Yamoa, NHC Ltd.

Number of Patients: 73
Mean duration of Hayfever: 19.8 yrs.
Age Range of Patients: 1 - 66 yrs.
45% male. 41% female. 14% unknown gender.
9 patients belonged to the 0-29 year old bracket.
56 patients belonged to the 30-59 year old bracket.
5 patients belonged to the 60-89 year old bracket.

54% of patients described themselves as 'white'. 26% were African. 9% were Afro-Carribean. 5% were Asian. 6% were of unknown ethnic origin.

The longest time a patient took Yamoa for for hayfever was 6 months; the shortest amount of time was one week. The average length of time Yamoa was taken for was 1.6 months.

General Safety

Safety:

Purity:

Yamoa Powder is derived only from a natural and organically grown bark; it is subjected to quality and standardisation checks and hermetically packed under food grade hygiene conditions as a supplement that is taken orally.

Side effects:

Over many years and hundreds of patients using Yamoa, both Drs Eccles and Williams have neither seen nor had reported to them any cases of serious or irreversible adverse effects. There have been single reports of a rash, of water-retention, a tickly cough, a stomach ache and palpitations (the latter in association with taking blood pressure tablets - see Drug Interactions below).

Some people may experience what is termed a 'healing reaction' (sometimes known as a healing 'crisis') initially with Yamoa. This is when symptoms appear to worsen before they start to improve, which can be quite alarming particularly for asthma sufferers. Please bear this in mind, and although it is rare with Yamoa, it is common with many herbal and complimentary therapies. Please be sure, particularly if you suffer from respiratory attacks such as in asthma, that you carry your emergency medication with you at all times, even if you feel Yamoa has helped you combat your condition.

Caution: Purely as a precaution and in the absence of additional data, we do not recommend you take Yamoa if you are pregnant or breastfeeding, or if you are on blood pressure medication. We also do not recommend mixing the powder with honey or another sweet carrier if you suffer from fungal infections in the respiratory tract. If you find you are experiencing any adverse symptoms from taking Yamoa, please let us know. [Click here to report].

Drug Interactions with Yamoa Powder:

The manufacturer has had feedback from just one lady regarding a possible interaction between Yamoa Powder and her daily dose of 0.5mg of Norvasc (blood pressure drug), resulting in palpitations which increased in severity the longer she used the powder. She ceased use of the powder, and her palpitations disappeared after a few days. This is the only drug interaction known to date.